MedPath

Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation

Completed
Conditions
Inflammation
Dermatomyositis
Myocardial Repolarization
Interventions
Other: disease
Registration Number
NCT06002750
Lead Sponsor
The Third People's Hospital of Hangzhou
Brief Summary

The goal of this observational study is to investigate ventricular repolarization utilizing Tp-e intervals and Tp-e/QT ratios in patients with DM. The main questions it aims to answer are:

* 1.Exploring the changes in ventricular repolarization parameters (QT interval, QTc interval, QTd, Tp-e interval, Tp-e/QT ratio) in patients with dermatomyositis, providing quantifiable indicators for early detection of arrhythmia in dermatomyositis patients;

* 2.Exploring the role of inflammation in ventricular repolarization in DM patients, providing a basis for in-depth research on the diagnosis and prevention of arrhythmia in DM patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Regardless of gender, registered residence and education level, voluntarily participate in this study and sign the informed consent form.

Clinical diagnosis of Dermatomyositis.

Exclusion Criteria

Previous history of heart disease (such as myocardial infarction, cardiac pacing, congenital heart disease, ischemic heart disease, etc.), chronic kidney disease, etc; Patients with other connective tissue diseases; Pregnant and lactating women.

Taking drugs that affect electrocardiogram indicators, such as macrolides, quinolones, quinidine, amiodarone, antipsychotic drugs, etc.

Patients with severe lack of case data.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Dermatomyositis patientsdisease-
Primary Outcome Measures
NameTimeMethod
the Tp-e interval and Tp-e/QT ratio were positively correlated with Inflammation.November 2011 to November 2022
QTc, Tp-e interval, and Tp-e/QT ratio were increased in DM patients.November 2011 to November 2022
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Third People's Hospital of Hangzhou

🇨🇳

Zhejiang, Hangzhou, China

© Copyright 2025. All Rights Reserved by MedPath